Home > (5alpha)-3,14-Dihydroxy-17-prop-2-en-1-yl-4,5-epoxymorphinan-6-one > (5alpha)-3,14-Dihydroxy-17-prop-2-en-1-yl-4,5-epoxymorphinan-6-one(465-65-6)
(5alpha)-3,14-Dihydroxy-17-prop-2-en-1-yl-4,5-epoxymorphinan-6-one(465-65-6)
Supplier Product Identification
Physical and Chemical Properties
First Aid Measures
Handling and Storage
Hazards Identification
Exposure Controls/Personal Protection
Fire Fighting Measures
Accidental Release Measures
Stability and Reactivity
Product Identification
Product Name
(5alpha)-3,14-Dihydroxy-17-prop-2-en-1-yl-4,5-epoxymorphinan-6-one
(5alpha)-3,14-Dihydroxy-17-prop-2-en-1-yl-4,5-epoxymorphinan-6-one
Synonyms
17-Allyl-4,5alpha-epoxy-3,14-dihydroxymorphinan-6-one
1-n-Allyl-14-Hydroxynordihydromorphinone
1-n-Allyl-7,8-dihydro-14-hydroxynormorphinone
n-Allyl-Noroxymorphone
17-Allyl-4,5alpha-epoxy-3,14-dihydroxymorphinan-6-one
1-n-Allyl-14-Hydroxynordihydromorphinone
1-n-Allyl-7,8-dihydro-14-hydroxynormorphinone
n-Allyl-Noroxymorphone
CAS
465-65-6
465-65-6
Formula
C19H21NO4
C19H21NO4
Molecular Weight
327.38
327.38
EINECS
207-365-7
207-365-7
RTECS
QD2260000
QD2260000
RTECS Class
Drug; Mutagen; Reproductive Effector
Drug; Mutagen; Reproductive Effector
Merck
12,6449
12,6449
Beilstein/Gmelin
1089071
1089071
Physical and Chemical Properties
Appearance
Crystals from ethyl acetate.
Crystals from ethyl acetate.
Solubility in water
Insoluble
Insoluble
Melting Point
184
184
pKa/pKb
7.39 (pKb)
7.39 (pKb)
Usage
Medication.
Medication.
First Aid Measures
Ingestion
Seek medical attention. If individual is drowsy or unconscious, do not give anything by mouth; place individual on the left side with the head down. Contact a physician, medical facility, or poison control center for advice about whether to induce vomiting. If possible, do not leave individual unattended.
Seek medical attention. If individual is drowsy or unconscious, do not give anything by mouth; place individual on the left side with the head down. Contact a physician, medical facility, or poison control center for advice about whether to induce vomiting. If possible, do not leave individual unattended.
Inhalation
If symptoms develop, move individual away from exposure and into fresh air. If symptoms persist, seek medical attention. If breathing is difficult, administer oxygen. Keep person warm and quiet; seek immediate medical attention.
If symptoms develop, move individual away from exposure and into fresh air. If symptoms persist, seek medical attention. If breathing is difficult, administer oxygen. Keep person warm and quiet; seek immediate medical attention.
Skin
Naloxone has a poor bioavailability when given orally, thus systemic adverse effects would be limited and gastrointestinal decontamination is rarely needed. See recommendations in the parenteral exposure section for treatment information.
Naloxone has a poor bioavailability when given orally, thus systemic adverse effects would be limited and gastrointestinal decontamination is rarely needed. See recommendations in the parenteral exposure section for treatment information.
Eyes
If symptoms develop, immediately move individual away from exposure and into fresh air. Flush eyes gently with water for at least 15 minutes while holding eyelids apart; seek immediate medical attention.
If symptoms develop, immediately move individual away from exposure and into fresh air. Flush eyes gently with water for at least 15 minutes while holding eyelids apart; seek immediate medical attention.
Handling and Storage
Storage
Protect from excessive light.Should be protected from excessive moisture and exposure to air.Should be stored below 30C.
Protect from excessive light.Should be protected from excessive moisture and exposure to air.Should be stored below 30C.
Handling
All chemicals should be considered hazardous. Avoid direct physical contact. Use appropriate, approved safety equipment. Untrained individuals should not handle this chemical or its container. Handling should occur in a chemical fume hood.
All chemicals should be considered hazardous. Avoid direct physical contact. Use appropriate, approved safety equipment. Untrained individuals should not handle this chemical or its container. Handling should occur in a chemical fume hood.
Hazards Identification
Inhalation
Increased respiratory rate may be seen with large doses. Pulmonary edema has been noted in a few cases of therapeutic use.
Increased respiratory rate may be seen with large doses. Pulmonary edema has been noted in a few cases of therapeutic use.
Exposure Controls/Personal Protection
Personal Protection
Chemical splash goggles in compliance with OSHA regulations are advised; however, OSHA regulations also permit other type safety glasses. Whre chemical resistant gloves. To prevent repeated or prolonged skin contact, wear impervious clothing and boots.
Chemical splash goggles in compliance with OSHA regulations are advised; however, OSHA regulations also permit other type safety glasses. Whre chemical resistant gloves. To prevent repeated or prolonged skin contact, wear impervious clothing and boots.
Respirators
Use NIOSH/MSHA approved respirator appropriate for exposure of concern.
Use NIOSH/MSHA approved respirator appropriate for exposure of concern.
Exposure Effects
With therapeutic use - seizures have been rarely seen with therapeutic use. Memory impairment has been reported in high dose therapy. Pregnancy Category B <br>No data were available to assess the teratogenic potential of this agent. <br>Naloxone is not known to produce adverse neonatal effects other than the possible precipitation of withdrawal symptoms in narcotic addicted mothers and their infants. Naloxone is clearly the drug of choice over nalorphine to reverse respiratory depression in the neonate.
With therapeutic use - seizures have been rarely seen with therapeutic use. Memory impairment has been reported in high dose therapy. Pregnancy Category B <br>No data were available to assess the teratogenic potential of this agent. <br>Naloxone is not known to produce adverse neonatal effects other than the possible precipitation of withdrawal symptoms in narcotic addicted mothers and their infants. Naloxone is clearly the drug of choice over nalorphine to reverse respiratory depression in the neonate.
Fire Fighting Measures
Fire Fighting
Wear a self-contained breathing apparatus in pressure-demand, MSHA/NIOSH (approved or equivalent), and full protective gear. During a fire, irritating and highly toxic gases may be generated by thermal decomposition or combustion. Use agent most appropriate to extinguish fire.
Wear a self-contained breathing apparatus in pressure-demand, MSHA/NIOSH (approved or equivalent), and full protective gear. During a fire, irritating and highly toxic gases may be generated by thermal decomposition or combustion. Use agent most appropriate to extinguish fire.
Accidental Release Measures
Small spills/leaks
Evacuate area and ventilate. Wear protective equipment. If required, use an inert absrobent. Sweep up and place in an appropriate container for disposal. Wash contaminated surfaces.
Evacuate area and ventilate. Wear protective equipment. If required, use an inert absrobent. Sweep up and place in an appropriate container for disposal. Wash contaminated surfaces.
Stability and Reactivity
Stability
Not particularly hygroscopic; can oxidize; relatively stable in heat hydrochloride.
Not particularly hygroscopic; can oxidize; relatively stable in heat hydrochloride.
Incompatibilities
Strong oxidizing agents.
Strong oxidizing agents.
Contact
More
- Company Name:Sinopharm Chemical Reagent Co,Ltd.
- Tel:86-21-63210123
- Fax:86-21-63290778 86-21-63218885
- WebSite:http://www.reagent.com.cn
- Company Name:Shanghai Fuhe Chemistry Technology Co., Ltd.
- Tel:0086-21-67651709
- Fax:0086-21-67651705
- WebSite:https://www.chemicalbook.com/ShowSupplierProductsList15402/0.htm
- Company Name:Artis Chemistry (Shanghai) Co. Ltd.
- Tel:86-21-60936353
- Fax:86-21-60936352
- WebSite:https://www.chemicalbook.com/ShowSupplierProductsList15631/0.htm
- Company Name:Shanghai T&W Pharmaceutical Co., Ltd.
- Tel:+86 21 61551611
- Fax:+86 21 50676805
- WebSite:http://www.trustwe.com
- Company Name:Nanjing Sunlida Biological Technology Co., Ltd.
- Tel:025-57798810
- Fax:025-57019371
- WebSite:http://www.sunlidabio.com